Sands Capital Ventures, LLC Top Holdings and 13F Report (2024) About Sands Capital Ventures, LLCInvestment ActivitySands Capital Ventures, LLC has $459.73 million in total holdings as of March 31, 2024.Sands Capital Ventures, LLC owns shares of 21 different stocks, but just 7 companies or ETFs make up 80% of its holdings.Approximately 27.11% of the portfolio was purchased this quarter.About 3.70% of the portfolio was sold this quarter.This quarter, Sands Capital Ventures, LLC has purchased 20 new stocks and bought additional shares in 7 stocks.Sands Capital Ventures, LLC sold shares of 5 stocks and completely divested from 1 stock this quarter.Largest Holdings KLAVIYO INC $143,131,421NU $72,739,207DOORDASH INC $68,331,788Inhibikase Therapeutics $35,587,500Coupang $20,325,170 Largest New Holdings this Quarter Inhibikase Therapeutics $35,587,500 Holdingmonday.com $11,366,572 Holding Largest Purchases this Quarter Inhibikase Therapeutics 10,950,000 shares (about $35.59M)Coupang 912,781 shares (about $20.06M)NU 1,522,357 shares (about $15.77M)Datadog 96,382 shares (about $13.77M)monday.com 48,278 shares (about $11.37M) Largest Sales this Quarter Snowflake 69,297 shares (about $10.70M)DOORDASH INC 15,995 shares (about $2.68M)KLAVIYO INC 44,631 shares (about $1.84M)BIOAGE LABS INC 300,000 shares (about $1.74M)Spruce Biosciences 71,190 shares (about $29.90K) Sector Allocation Over TimeMap of 500 Largest Holdings ofSands Capital Ventures, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorKLAVIYO INC$143,131,421$1,840,582 ▼-1.3%3,470,69431.1%COM SER ANUNU$72,739,207$15,771,618 ▲27.7%7,021,15915.8%FinanceDOORDASH INC$68,331,788$2,683,161 ▼-3.8%407,34314.9%CL AIKTInhibikase Therapeutics$35,587,500$35,587,500 ▲New Holding10,950,0007.7%MedicalCPNGCoupang$20,325,170$20,062,927 ▲7,650.5%924,7124.4%Retail/WholesalePATHUiPath$20,141,245$5,458,068 ▲37.2%1,584,6774.4%Business ServicesDDOGDatadog$13,972,927$13,772,024 ▲6,855.0%97,7883.0%Computer and TechnologyACRVAcrivon Therapeutics$12,778,0820.0%2,122,6052.8%MedicalMNDYmonday.com$11,366,572$11,366,572 ▲New Holding48,2782.5%Computer and TechnologyTARSTarsus Pharmaceuticals$9,412,9000.0%170,0002.0%MedicalIOTSamsara$8,680,766$8,542,181 ▲6,163.9%198,6901.9%Computer and TechnologyTOSTToast$8,439,269$8,276,957 ▲5,099.4%231,5301.8%Computer and TechnologyTXG10x Genomics$6,918,2170.0%481,7701.5%MedicalSNOWSnowflake$6,023,071$10,700,150 ▼-64.0%39,0071.3%Computer and TechnologyABOSAcumen Pharmaceuticals$5,877,3690.0%3,417,0751.3%MedicalCRWDCrowdStrike$5,850,936$5,775,319 ▲7,637.6%17,1001.3%Computer and TechnologyBIOAGE LABS INC$4,552,984$1,737,000 ▼-27.6%786,3531.0%COMCADLCandel Therapeutics$3,522,6650.0%405,8370.8%MedicalTSHATaysha Gene Therapies$1,254,0300.0%724,8730.3%MedicalMASS908 Devices$521,9680.0%237,2580.1%MedicalSPRBSpruce Biosciences$300,643$29,900 ▼-9.0%715,8170.1%MedicalGTLBGitLab$0$33,913 ▼-100.0%00.0%Computer and TechnologyShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
